In the twentieth century, however, scandals involving unregulated medical products helped swing the balance of power toward regulation
While the public advisory committee meetings convened in 2024 resulted in the PCAC voting against inclusion of all previous peptides under review, finding that they posed unacceptable safety risks for compounding, whether the current regulatory and political environment will produce a different outcome at the July meeting remains to be seen
Journal of Orthopaedic Research, 2015, 33(7): 1024-1033
We invite you to nominate worthy individuals by completing the attached form and return by email to Ruth Ryan, RN ([email protected])
Heffernan MA et al
Its important to emphasize up front that most of the dosing data for DSIP comes from a research setting, research and anecdotal reports, not formal regulatory guidance or definitive dosing guidelines